General Information of Drug Transporter (DT)
DT ID DTD0415 Transporter Info
Gene Name SLC58A2
Transporter Name Tumor suppressor candidate 3
Gene ID
7991
UniProt ID
Q13454
Post-Translational Modification of This DT
Overview of SLC58A2 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-Disulfide bond X-Methylation X-N-glycosylation X-Phosphorylation X-S-sulfhydration X-Ubiquitination X: Amino Acid

Acetylation

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC58A2 [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

72

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC58A2 Lysine 72 has the potential to affect its expression or activity.

Disulfide bond

  Cystine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence TUSC3 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

99

Experimental Method

Co-Immunoprecipitation

Detailed Description

Disulfide bond (-SSR) at TUSC3 Cystine 99 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence TUSC3 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

102

Experimental Method

Co-Immunoprecipitation

Detailed Description

Disulfide bond (-SSR) at TUSC3 Cystine 102 has the potential to affect its expression or activity.

Methylation

  Arginine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC58A2 [3]

Role of PTM

Potential impacts

Modified Residue

Arginine

Modified Location

63

Experimental Method

Co-Immunoprecipitation

Detailed Description

Methylation at SLC58A2 Arginine 63 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC58A2 [3]

Role of PTM

Potential impacts

Modified Residue

Arginine

Modified Location

67

Experimental Method

Co-Immunoprecipitation

Detailed Description

Methylation at SLC58A2 Arginine 67 has the potential to affect its expression or activity.

  Proline

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC58A2 [4]

Role of PTM

Potential impacts

Modified Residue

Proline

Studied Phenotype

Gastric cancer [ICD11: 2B72]

Experimental Method

Co-Immunoprecipitation

Detailed Description

Methylation at SLC58A2 Proline has the potential to affect its expression or activity.

N-glycosylation

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Affecting the etiology of intellectual disability SLC58A2 [5]

Role of PTM

Influencing the Disease Progression

Modified Residue

Tyrosine

Studied Phenotype

Autosomal recessive intellectual disability [ICD11:6A00.Z]

Experimental Method

Co-Immunoprecipitation

Detailed Description

Glycosylation at SLC58A2 Tyrosine have been reported to affect the etiology of intellectual disability.

Phosphorylation

  Serine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC58A2 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

115

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC58A2 Serine 115 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC58A2 [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

327

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC58A2 Serine 327 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC58A2 [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

331

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC58A2 Serine 331 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC58A2 [6]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

109

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC58A2 Tyrosine 109 has the potential to affect its expression or activity.

S-sulfhydration

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence TUSC3 [8]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

123

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-sulfhydration (-SSH) at TUSC3 Cystine 123 has the potential to affect its expression or activity.

Ubiquitination

  Asparagine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC58A2 [9] , [10]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

124

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC58A2 Asparagine 124 has the potential to affect its expression or activity.

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC58A2 [9] , [10]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

180

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC58A2 Lysine 180 has the potential to affect its expression or activity.
References
1 Lysine Acetylation and Succinylation in HeLa Cells and their Essential Roles in Response to UV-induced Stress. Sci Rep. 2016 Jul 25;6:30212.
2 iCysMod: an integrative database for protein cysteine modifications in eukaryotes. Brief Bioinform. 2021 Sep 2;22(5):bbaa400. (ID: Q13454)
3 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: TUSC3_HUMAN)
4 The systems of molecular genetic markers under cancer of stomach. Klin Lab Diagn. 2013 Nov;(11):12-5.
5 Homozygous deletion in TUSC3 causing syndromic intellectual disability: a new patient. Am J Med Genet A. 2013 Aug;161A(8):2084-7.
6 Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
7 CDC25B mediates rapamycin-induced oncogenic responses in cancer cells. Cancer Res. 2009 Mar 15;69(6):2663-8.
8 Direct Proteomic Mapping of Cysteine Persulfidation. Antioxid Redox Signal. 2020 Nov 20;33(15):1061-1076.
9 A data set of human endogenous protein ubiquitination sites. Mol Cell Proteomics. 2011 May;10(5):M110.002089.
10 Ubiquitin ligase substrate identification through quantitative proteomics at both the protein and peptide levels. J Biol Chem. 2011 Dec 2;286(48):41530-41538.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.